Table 3.

Treatment of DM in the Two Study Groups

	Allopurinol Users N=96	Control Subjects N=96	P-Value
DM treatment
Insulin	61 (63.5%)	63 (65.6%)	0.763
OHA	45 (46.9%)	52 (54.2%)	0.312
Sulphonylureas	19 (19.8%)	23 (24.0%)	0.485
Biguanides	35 (36.5%)	45 (46.9%)	0.143
Meglitinides	0	0	–
Thiazolidinediones	3 (3.1%)	4 (4.2%)	0.700
Alpha glucosidase inhibitors	2 (2.1%)	2 (2.1%)	1.000
Dipeptidyl peptidase-4 inhibitors	17 (17.7%)	9 (9.4%)	0.092
Glucagon like peptide-1 analogue	0	0	–

Abbreviations: DM, diabetes mellitus; OHA, oral hypoglycemic agents.